This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas such ...

The FDA has approved Johnson & Johnson’s Tecvayli plus Darzalex Faspro for adults with relapsed or refractory multiple myeloma following one to three prior therapies, including a proteasome inhibitor ...

The collaboration will make facility-level flexibility a standard capability across every InfraPartners AI data center ...